Fri, 16 May 2025 11:13:42 -0400

The FDA and the CDC are recommending a pause in the use of Ixchiq (Chikungunya Vaccine, Live) in individuals 60 years of age and older while the Agencies investigate postmarketing reports of serious adverse events, including neurologic and cardiac events, in individuals who have received the vaccine

Thu, 08 May 2025 11:03:12 -0400

Indiqué chez l'enfant (de 2 à 18 ans) dans le traitement de l'arthrite juvénile idiopathique : oligoarthrite idiopathique juvénile extensive polyarthrite avec facteur rhumatoïde (FR+) polyarthrite sans facteur rhumatoïde (FR-) arthrite juvénile idiopathique, forme multisystémique sans caractéristiques multisystémiques actives arthrite psoriasique enthésite avec arthrite

The FDA is alerting consumers, tattoo artists, and retailers of the potential for serious injury from use of tattoo inks that are contaminated with bacteria, including Pseudomonas aeruginosa.